Efficacy and safety of first- and second-line antibiotics for cellulitis and erysipelas: a network meta-analysis of randomized controlled trials
Authors:
Open Access
- 6 September 2024
- journal article
- review article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (8) , 1-17
Abstract
This study systematically evaluated and ranked the efficacy of first- and second-line antibiotics antibiotic options for the clinical management of cellulitis and erysipelas through a network meta-analysis approach. From inception to July 04, 2024, a search for relevant randomized clinical trials (RCTs) was carried out using several databases. Antibiotics including azithromycin, cefaclor, cephalexin, cloxacillin, erythromycin, cephalexin plus trimethoprim-sulfamethoxazole, cephalexin plus placebo, flucloxacillin, clindamycin, ceftriaxone, penicillin, roxithromycin, and pristinamycin were assessed regarding cure rate, the eradication of baseline pathogens, diarrhea or vomiting, and rash. In total, 10 RCTs with 1,936 cellulitis or erysipelas patients were eligible for inclusion. There were no significant differences in the cure rates for cellulitis among the antibiotics analysed, with cefaclor demonstrating the most favorable profile for curative outcomes. In terms of side effects, ceftriaxone was identified as the least likely to induce diarrhea or vomiting. For erysipelas, pristinamycin showed the most promising results in achieving cure rates. Although a comparison of the three antibiotics revealed no significant differences in rash as a side effect in erysipelas, pristinamycin was observed to carry the highest risk for rash. Our findings indicate no significant differences in cure rates among antibiotics for cellulitis. However, ceftriaxone had the fewest gastrointestinal side effects. Pristinamycin showed the highest cure rates for erysipelas but with a higher risk of rash. Future research should focus on optimizing antibiotic selection for cellulitis and erysipelas.Keywords
This publication has 37 references indexed in Scilit:
- High-dose cephalexin for cellulitis: a pilot randomized controlled trialCanadian Journal of Emergency Medicine, 2023
- The impact of antibiotics on clinical response over time in uncomplicated cellulitis: a systematic review and meta-analysisInfection, 2022
- Cellulitis: A Review of Current Practice Guidelines and Differentiation from PseudocellulitisAmerican Journal of Clinical Dermatology, 2021
- Effect of Cephalexin Plus Trimethoprim-Sulfamethoxazole vs Cephalexin Alone on Clinical Cure of Uncomplicated CellulitisJAMA, 2017
- Overtreatment of nonpurulent cellulitisJournal of Hospital Medicine, 2016
- Meta-analysis of randomised trials comparing a penicillin or cephalosporin with a macrolide or lincosamide in the treatment of cellulitis or erysipelasInfection, 2016
- Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast CancerJAMA Oncology, 2015
- Éruption cutanée secondaire à la prise de pristinamycine mimant un pityriasis rosé de GibertAnnales de Dermatologie et de Vénéréologie, 2014
- Checking consistency in mixed treatment comparison meta‐analysisStatistics in Medicine, 2010
- Double-blind, double-dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991